Loomis Sayles & CO L P Novo Nordisk A S Transaction History
Loomis Sayles & CO L P
- $77.3 Billion
- Q2 2025
A detailed history of Loomis Sayles & CO L P transactions in Novo Nordisk A S stock. As of the latest transaction made, Loomis Sayles & CO L P holds 12,576,031 shares of NVO stock, worth $622 Million. This represents 1.12% of its overall portfolio holdings.
Number of Shares
12,576,031
Previous 12,388,242
1.52%
Holding current value
$622 Million
Previous $860 Million
0.9%
% of portfolio
1.12%
Previous 1.24%
Shares
33 transactions
Others Institutions Holding NVO
# of Institutions
1,704Shares Held
294MCall Options Held
13.7MPut Options Held
19.7M-
Bank Of America Corp Charlotte, NC14.7MShares$728 Million0.08% of portfolio
-
Morgan Stanley New York, NY14.3MShares$707 Million0.07% of portfolio
-
Capital International Investors Los Angeles, CA11.6MShares$575 Million0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11MShares$544 Million0.31% of portfolio
-
Fayez Sarofim & CO Houston, TX10.5MShares$520 Million1.8% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $112B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...